 |
Senior Member
|
|
Join Date: Aug 2006
Posts: 1,860
|
|
|
Senior Member
Join Date: Aug 2006
Posts: 1,860
|
patent for lead author
I am not suggesting that the following info skewed the lead author's interpretation of the data from the study; just think it is emblematic of the time: $$$$$$$
Seems the lead author, dr. Benjamin Wolozin, has a patent for using statins to reduce the risk of onset of alzheimer's--(hopefully this willl not be upheld !!)
Patents
Methods for treating, preventing, and reducing the risk of the onset
of Alzheimer's disease using an HMG CoA reductase inhibitor
United States Patent 6,472,421 / Wolozin / October 29, 2002
Inventors: Wolozin; Benjamin (Hinsdale, IL)
Assignee: Nymox Corporation (St. Laurent, CA)
Appl. No.: 190439
Filed: November 13, 1998
I should have begun with the obvious--that the study reported is an observational study-not an experimental study.
madelyn
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.
~ Jean-Martin Charcot
The future is already here — it's just not very evenly distributed. William Gibson
|